We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Assessing the Effectiveness of Intravenous Ertapenem in HS Patients
Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
Prurigo Nodularis: Recent Advancements in Addressing Unmet Needs
Guselkumab Shows Significant Clearance of Scalp Psoriasis in People of Color
Understanding the Impact of Depressive Symptoms in Patients with Psoriasis
Charles Turck, PharmD, BCPS, BCCCP
Neda Shahriari, MD
Strategies for the Long-Term Control of Atopic Dermatitis
Raj Chovatiya, MD, PhD
Melinda Gooderham, MSc, MD, FRCPC
Poster Pearl: Itch Control Matters Most to Patients with Moderate-to-Severe Atopic Dermatitis
Steven R. Feldman, MD, PhD
Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
Ananta Paine, PhD
FDA Approves New Treatment for Moderate-to-Severe Plaque Psoriasis
Biosimilars for the Treatment of Psoriasis
Biosimilars in Psoriasis: The Future of Treatment
Treating Atopic Dermatitis: A Look at the Current & Future Landscape
Jennifer Soung, MD
Einjuan James Song, MD, FAAD
Applying Shared Decision-Making to Atopic Dermatitis Care
Matthew Zirwas, MD
Douglas DiRuggiero, DMSc, PA-C
Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors
George Han, MD, PhD
From Pathophysiology to Therapeutic Progress: TYK2's Significance in Plaque Psoriasis
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education